UVA Researchers Reverse Severe Epilepsy in Mice Using Gene Editing

Breakthrough study targets underlying genetic mutation for rare neurological disorder

Apr. 7, 2026 at 3:04pm

Got story updates? Submit your updates here. ›

A highly structured abstract painting in soft blues, greens, and grays, featuring sweeping geometric arcs, concentric circles, and precise botanical spirals, conceptually representing the complex genetic and neurological forces involved in a rare form of severe epilepsy.Gene-editing breakthrough offers new hope for treating rare, debilitating neurological disorders.University of Virginia Today

Researchers at the University of Virginia School of Medicine have successfully reversed severe epilepsy in laboratory mice using advanced gene-editing technology. The study focused on SCN8A developmental and epileptic encephalopathy (DEE), a rare genetic condition characterized by persistent seizures and significant neurological impairment.

Why it matters

This achievement marks a notable step forward in understanding and potentially treating genetic neurological disorders. SCN8A DEE is known for its debilitating effects, including frequent seizures that are resistant to conventional treatments, making this breakthrough particularly significant.

The details

The research utilized next-generation gene-editing techniques to target the underlying genetic mutation responsible for SCN8A DEE. Scientists observed that modifying the faulty gene effectively halted the progression of severe seizures in the mice, demonstrating the potential for precise interventions in similar conditions.

  • The study was conducted in 2026 at the University of Virginia School of Medicine.

The players

University of Virginia School of Medicine

A leading academic medical center and research institution located in Charlottesville, Virginia.

Got photos? Submit your photos here. ›

What’s next

While further studies are required to assess safety and efficacy in humans, this development highlights promising possibilities for addressing complex genetic diseases through targeted molecular approaches.

The takeaway

This breakthrough in gene editing technology demonstrates the potential to treat severe, treatment-resistant neurological disorders by directly addressing their underlying genetic causes, opening up new avenues for precision medicine.